```
[Federal Register Volume 62, Number 145 (Tuesday, July 29, 1997)]
[Notices]
[Pages 40533-40534]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-19909]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Notice of Meeting

AGENCY: Office of Disease Prevention and Health Promotion, HHS.

ACTION: Commission of dietary supplement labels: notice of meeting #9.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) is providing 
notice of the ninth meeting of the Commission on dietary supplement 
labels.

DATES: The Commission intends to hold its meeting on August 14, 1997, 
from 8:30 a.m. to 4:30 p.m. and on August 15, 1997, from 8:30 a.m. to 
approximately 3:00 p.m., E.S.T., at the Hyatt Regency Reston, Reston 
Town Center, 1800 Presidents Street, Reston, Virginia 20190. The 
meeting is open to the public; seating is limited.

FOR FURTHER INFORMATION CONTACT: Kenneth D. Fisher, Ph. D., Executive 
Director, Commission on Dietary Supplement Labels, Office of Disease 
Prevention and Health Promotion, Room 738G, Hubert H. Humphrey 
Building, 200 Independence Ave. S.W., Washington, D.C. 20201, (202) 
690-7102.

SUPPLEMENTARY INFORMATION: Pub. L. 103-417, Section 12, authorized the 
establishment of a Commission on Dietary Supplement Labels whose seven 
members have been appointed by the President. The appointments to the 
Commission by the President and the establishment of the Commission by 
the Secretary of Health and Human Services reflect the commitment of 
the President and the Secretary to the development of a sound and 
consistent regulatory policy on labeling of dietary supplements.
    The Commission is charged with conducting a study and providing 
recommendations for regulation of label claims and statements for 
dietary supplements, including the use of

[[Page 40534]]

supplemental literature in connection with their sale and, in addition, 
procedures for evaluation of label claims. The Commission is evaluating 
how best to provide truthful, scientifically valid, and non-misleading 
information to consumers in order that they may make informed health 
care choices for themselves and their families. The Commission's study 
report may include recommendations on legislation, if appropriate and 
necessary.
    The Commission made a draft of its report available for public 
comment on June 24, 1997. The purpose of meeting #9 is to review 
comments and information received from the public and to discuss 
preparation of the Commission's final report.
    The Commission meeting agenda will include approval of minutes of 
the previous meeting, review of comments and information submitted by 
the public, and discussion of possible revisions of the draft report 
and procedures for final report completion. The open meeting may be 
recessed for short time periods on Thursday afternoon, August 14, 1997, 
and on Friday morning, August 15, 1997, at the call of the Chair, to 
allow members of the Commission to redraft portions of the report. 
Following such recesses, if any, the revisions will be presented to the 
full Commission in its open meeting.
    The meeting is open to the public, however seating is limited. If 
you will require a sign language interpreter, please call Sandra 
Saunders (202) 690-7102 by 4:30 p.m. E.S.T. on August 4, 1997.

    Dated: July 17, 1997.
Susanne A. Stoiber,
Acting Deputy Assistant Secretary for Health, (Disease Prevention and 
Health Promotion), U.S. Department of Health and Human Services.
[FR Doc. 97-19909 Filed 7-28-97; 8:45 am]
BILLING CODE 4160-17-M
```